Press Releases
Search
-
19 Feb 2014
BioFire Submits 510(k) Application to FDA for FilmArray® Gastrointestinal Panel
BioFire Diagnostics, LLC today announced that it has submitted the FilmArray Gastrointestinal (GI) Panel to the U.S. Food and Drug Administration (FDA) for 510(k) clearance. The comprehensive FilmArra...
-
27 Jan 2014
Appointment of Claire Giraut as bioMérieux’s Corporate Vice President & Chief Financial Officer
Marcy l’Etoile, France, January 27, 2014 — bioMérieux, a world leader in the field of in vitro diagnostics, announces that Claire Giraut has been appointed Corporate Vice President & Chief Financial O...
-
22 Jan 2014
Business Review for the year ended December 31, 2013
2013: solid 4.6% organic growth in sales At the top end of the target range announced early in the year Faster organic growth in North America and firmer business in Western Europe Sustained fast grow...
-
16 Jan 2014
bioMérieux finalizes acquisition of the U.S. company BioFire, specialized in molecular biology
Marcy l'Etoile, France, January 16, 2014 - bioMérieux, a world leader in the field of in vitro diagnostics, announces that it has finalized its acquisition of 100% ownership in BioFire Diagnostics Inc...
-
05 Dec 2013
bioMérieux is Moving Forward to a New Molecular Biology Workflow Solution for Reference or Centralized Laboratories
Marcy l'Étoile, France, December 5th, 2013 - bioMérieux, a world leader in the field of in vitro diagnostics, has announced that it is moving a new step forward to its comprehensive automation solutio...
-
28 Nov 2013
bioMérieux Announces Termination of its Collaboration with Biocartis in Molecular Biology
Marcy l'Etoile, France, November 28, 2013 - bioMérieux, a world leader in the field of in vitro diagnostics, and Biocartis have mutually agreed to end their collaboration to develop and commercialize ...
-
29 Oct 2013
bioMérieux launches the Parvovirus B19 R-gene® kit, a new ARGENE® test for the detection and quantification of the three Parvovirus B19 genotypes
Marcy l'Étoile, France, October 28, 2013 - bioMérieux, a world leader in the field of in vitro diagnostics, has announced the launch of the Parvovirus B19 R-gene® kit, a new CE-marked ARGENE® real-tim...
-
23 Oct 2013
Business Review for the Nine Months Ended September 30, 2013
Sales: 2013 objective confirmed Very good third quarter with sales up 7.4%* (5.7%* excluding R&D-related revenue) Robust organic growth of 3.9% over the first nine months (3.3% excluding R&D-related r...
-
07 Oct 2013
Successful placement of Inaugural €300-Million Issue of 7-Year Bonds
Marcy l'Etoile, France, October 7, 2013 - bioMérieux, a world leader in the field of in vitro diagnostics, announced the placement to institutional investors of its first issue of seven-year euro-bond...
-
30 Sep 2013
bioMérieux lance VIDAS® 25 OH Vitamine D TOTAL, un nouveau test pour le dosage de la vitamine D
Marcy l'Étoile, France, September 30, 2013 - bioMérieux, a world leader in the field of in vitro diagnostics, has announced the launch of VIDAS® 25 OH Vitamin D Total for the measurement of total vita...
-
03 Sep 2013
First-Half 2013 Results
Sales: €754 million, with a marked acceleration in the second quarter (+ 4%*) Operating income before non-recurring items in line with objectives: €125 million, or 16.6% of sales Major investments in ...
-
03 Sep 2013
bioMérieux makes a significant acquisition in molecular biology in the U.S.
With the acquisition of BioFire, bioMérieux consolidates its position as a major player in infectious disease diagnostics With a complete range of technologies for clinical microbiology diagnostics, b...
-
22 Aug 2013
bioMérieux Announces U.S. FDA Clearance for VITEK® MS, a Revolutionary Technology which Reduces Microbial Identification from Days to Minutes Reinforcing Medical Value of Diagnostics
Marcy L’Etoile (France) and Durham, NC - August 21, 2013 - bioMérieux today announced that it has been granted U.S. FDA 510(k) de novo clearance for VITEK® MS, the first clinical mass spectrometry MAL...
-
18 Jul 2013
First-Half 2013 Business Review
Sharp acceleration in organic growth in the second quarter, up 4% Double-digit growth in emerging markets up 14% Sustained gains in North America Industrial application sales up 11% 2013 organic sales...
-
27 Jun 2013
International Experts Join Forces against Superbugs at the 4th World Forum on Healthcare-Associated Infections and Antimicrobial Resistance
bioMérieux commits to supporting expert-defined global priorities...